RAPID COVID COAG
Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic
Registration:
Sponsors:
St. Michael's Hospital, Toronto
Collaborator: University of Vermont Medical Center
Status:
Recruiting
Design
This study is a 2-arm, parallel, pragmatic, multi-centre, open-label randomized controlled trial to determine the effect of therapeutic anticoagulation on the composite outcome of ICU admission, invasive mechanical ventilation and/or death in hospitalized patients with COVID-19.
Participating Sites
Lead Network:
CanVECTOR
Countries:
Canada, The Netherlands, USA,Lead Investigators
Dr. Michelle Sholzberg, MD, MDCM
Michelle.Sholzberg@unityhealth.toSubscribe